(Q36936986)

English

Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience

scientific article published on June 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience (English)

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

author name string

Smit Singla

1

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Charles M LeVea

2

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Venkata K Pokuri

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Kristopher M Attwood

4

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Michael M Wach

5

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Garin M Tomaszewski

6

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Boris Kuvshinoff

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Renuka Iyer

8

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

publication date

1 June 2016

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Journal of gastrointestinal oncology

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

441-448

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Ki-67 is a reliable pathological grading marker for neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Long-term survival after surgical management of neuroendocrine hepatic metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Radioembolization of liver tumors with yttrium-90 microspheres

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Updated population-based review of carcinoid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Management of neuroendocrine liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Hepatic surgery for metastases from neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Neuroendocrine metastases of the liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

29 September 2017

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4880774

4 September 2018

Transarterial liver-directed therapies of neuroendocrine hepatic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/27284478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic neuroendocrine tumors: the impact of surgical resection on survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/27284478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27284478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroendocrine hepatic metastases: does aggressive management improve survival?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27284478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/27284478

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.21037/JGO.2016.02.02

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36936986&oldid=2136914270"